The 6th Epigenomics of Common Diseases conference will bring together leading scientists from the fields of epigenomics, genetics, and bioinformatics to discuss the latest developments in this fast-moving area.

Epigenetic variation plays an important role in disease processes and provides a promising focus for disease prediction, prevention, and treatment. Technological advancements in the past few years have fueled a dramatic increase in the scale, breadth, and availability of epigenomic reference data. In addition, novel developments such as single cell analysis and gene editing present exciting new opportunities. Associations between epigenetic variation, a variety of risk factors and the development of many diseases continue to emerge but causality has, in many instances, not yet been established.

This meeting will focus on epigenomic studies across of a range of common and other diseases including cancer, and will include approaches from a variety of different disciplines. It will explore technological and methodological developments and provide a forum to present and discuss recent advances in epigenomics of relevance to human disease.